fifty-seven patients referred to roswell park memorial institute between 1971-1975 with stage iii or iv epithelial ovarian cancer treated with prior radiation therapy were randomly allocated to treatment with melphalan , 5-fluorouracil ( 5-fu ) plus melphalan ( fume ) , actinomycin-d plus 5-fluorouracil plus melphalan ( acfume ) , actinomycin-d , or 5-fluorouracil plus cyclophosphamide ( acfucy ) .
C0010934
actinomycin-d
C0050547
acfucy